Events

Videos

Podcasts

Articles

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Nilanjan Ghosh, MD, PhD, discusses the role of minimal residual disease in chronic lymphocytic leukemia.

Dr. Ghosh on the Role of MRD in CLL 

Paolo Ghia, MD, PhD, discusses overall survival data with acalabrutinib in patients with relapsed/refractory chronic lymphocytic leukemia in the phase 3 ASCEND trial.

Dr. Ghia on Lack of OS Advantage With Acalabrutinib Per ASCEND Trial in CLL

The FDA has cleared the clonoSEQ® assay to identify and monitor minimal residual disease in blood or bone marrow from patients with chronic lymphocytic leukemia. 

FDA Clears First MRD Assay for Chronic Lymphocytic Leukemia

Othman Al-Sawaf, MD, discusses new safety signals with venetoclax plus obinutuzumab in the phase 3 CLL14 trial.

Dr. Al-Sawaf on New Safety Signals With Venetoclax/Obinutuzumab in the CLL14 Trial

Future Directions in CLL

Novel Therapies for CLL

PI3 Kinase Inhibitors in CLL

Therapeutic Sequencing in CLL

BTK Inhibitors in Relapsed/Refractory CLL

MURANO Trial Update in R/R CLL

Utility of MRD Testing in CLL Management

Venetoclax Combinations, Safety and Efficacy

Venetoclax and Obinutuzumab in CLL

Novel Therapies for Relapsed/Refractory CLL

Relapsed/Refractory CLL: Treatment Selection

BTK inhibitor With vs Without a CD20-Targeted Antibody

Second-Generation BTK Inhibitors in CLL

Therapies in the Pipeline for Frontline CLL

Telemedicine for Patients With CLL

BTK Inhibitors in CLL: Ibrutinib

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 